US 12,145,943 B2
Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
Yamin Zhang, Beijing (CN)
Assigned to ACTUATE THERAPEUTICS INC., Fort Worth, TX (US)
Filed by Actuate Therapeutics Inc., Fort Worth, TX (US)
Filed on Sep. 24, 2021, as Appl. No. 17/484,025.
Application 17/484,025 is a continuation of application No. 16/638,303, granted, now 11,136,334, previously published as PCT/US2018/046203, filed on Aug. 10, 2018.
Claims priority of provisional application 62/544,277, filed on Aug. 11, 2017.
Prior Publication US 2022/0009939 A1, Jan. 13, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 491/056 (2006.01); A61P 35/00 (2006.01)
CPC C07D 491/056 (2013.01) [A61P 35/00 (2018.01); C07B 2200/13 (2013.01)] 5 Claims
OG exemplary drawing
 
1. A solid form of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione, which is amorphous.